The NHS is offering a new pill called fampridine, which boosts nerves damaged by multiple sclerosis (MS) to help electrical ...

Fampridine boosts nerve signals to make it easier to walk, with up to 5,000 eligible.

Thousands of people with MS in England will be granted access to a drug that has been shown to improve walking speed in 43% ...

Fampridine helps electrical messages travel along nerves damaged by MS, allowing some people to walk more easily and improve ...

Thousands of people with multiple sclerosis (MS) in England will be offered a new drug on the NHS to help them walk more ...

Fampridine is the first medicine designed to improve walking in adults with MS and will now be routinely available on the NHS from today, NHS England has announced. Taken as a pill twice a day, ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions ...

ZURICH, April 22 (Reuters) - Swiss drugmaker Roche on Wednesday said it was submitting its experimental multiple ‌sclerosis drug fenebrutinib to global regulators after meeting late-stage trial goals ...

Add Yahoo as a preferred source to see more of our stories on Google. The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File ...